Chugai Pharmaceutical Co Ltd
TSE:4519

Watchlist Manager
Chugai Pharmaceutical Co Ltd Logo
Chugai Pharmaceutical Co Ltd
TSE:4519
Watchlist
Price: 8 224 JPY -0.11% Market Closed
Market Cap: 13.8T JPY

Intrinsic Value

The intrinsic value of one Chugai Pharmaceutical Co Ltd stock under the Base Case scenario is 4 349.61 JPY. Compared to the current market price of 8 224 JPY, Chugai Pharmaceutical Co Ltd is Overvalued by 47%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
4 349.61 JPY
Overvaluation 47%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Chugai Pharmaceutical Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Chugai Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Chugai Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Chugai Pharmaceutical Co Ltd.

Explain Valuation
Compare Chugai Pharmaceutical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Chugai Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Chugai Pharmaceutical Co Ltd

Current Assets 1.5T
Receivables 295B
Other Current Assets 1.2T
Non-Current Assets 623.1B
PP&E 463.6B
Intangibles 17.3B
Other Non-Current Assets 142.2B
Current Liabilities 208.4B
Other Current Liabilities 208.4B
Non-Current Liabilities 23.8B
Other Non-Current Liabilities 23.8B
Efficiency

Free Cash Flow Analysis
Chugai Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Chugai Pharmaceutical Co Ltd

Revenue
1.2T JPY
Cost of Revenue
-370.4B JPY
Gross Profit
843.3B JPY
Operating Expenses
-290.1B JPY
Operating Income
553.2B JPY
Other Expenses
-156.1B JPY
Net Income
397.2B JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Chugai Pharmaceutical Co Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional Operating Margin
Exceptional 3Y Average ROE
Positive ROIC
64/100
Profitability
Score

Chugai Pharmaceutical Co Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Chugai Pharmaceutical Co Ltd's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
93/100
Solvency
Score

Chugai Pharmaceutical Co Ltd's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Chugai Pharmaceutical Co Ltd

Wall Street analysts forecast Chugai Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Chugai Pharmaceutical Co Ltd is 8 963.76 JPY with a low forecast of 6 464 JPY and a high forecast of 11 707.5 JPY.

Lowest
Price Target
6 464 JPY
21% Downside
Average
Price Target
8 963.76 JPY
9% Upside
Highest
Price Target
11 707.5 JPY
42% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Chugai Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Chugai Pharmaceutical Co Ltd stock?

The intrinsic value of one Chugai Pharmaceutical Co Ltd stock under the Base Case scenario is 4 349.61 JPY.

Is Chugai Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 8 224 JPY, Chugai Pharmaceutical Co Ltd is Overvalued by 47%.

Back to Top